Literature DB >> 32098957

Measuring single cell divisions in human tissues from multi-region sequencing data.

Benjamin Werner1,2, Jack Case3,4, Marc J Williams5,6,7, Ketevan Chkhaidze3, Daniel Temko5, Javier Fernández-Mateos3, George D Cresswell3, Daniel Nichol3, William Cross5, Inmaculada Spiteri3, Weini Huang8,9, Ian P M Tomlinson10, Chris P Barnes6,11, Trevor A Graham12, Andrea Sottoriva13.   

Abstract

Both normal tissue development and cancer growth are driven by a branching process of cell division and mutation accumulation that leads to intra-tissue genetic heterogeneity. However, quantifying somatic evolution in humans remains challenging. Here, we show that multi-sample genomic data from a single time point of normal and cancer tissues contains information on single-cell divisions. We present a new theoretical framework that, applied to whole-genome sequencing data of healthy tissue and cancer, allows inferring the mutation rate and the cell survival/death rate per division. On average, we found that cells accumulate 1.14 mutations per cell division in healthy haematopoiesis and 1.37 mutations per division in brain development. In both tissues, cell survival was maximal during early development. Analysis of 131 biopsies from 16 tumours showed 4 to 100 times increased mutation rates compared to healthy development and substantial inter-patient variation of cell survival/death rates.

Entities:  

Mesh:

Year:  2020        PMID: 32098957      PMCID: PMC7042311          DOI: 10.1038/s41467-020-14844-6

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  30 in total

Review 1.  Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration.

Authors:  Steven A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 2.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

Authors:  Nicholas McGranahan; Charles Swanton
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

3.  Fundamental properties of unperturbed haematopoiesis from stem cells in vivo.

Authors:  Katrin Busch; Kay Klapproth; Melania Barile; Michael Flossdorf; Tim Holland-Letz; Susan M Schlenner; Michael Reth; Thomas Höfer; Hans-Reimer Rodewald
Journal:  Nature       Date:  2015-02-11       Impact factor: 49.962

4.  Clonal dynamics of native haematopoiesis.

Authors:  Jianlong Sun; Azucena Ramos; Brad Chapman; Jonathan B Johnnidis; Linda Le; Yu-Jui Ho; Allon Klein; Oliver Hofmann; Fernando D Camargo
Journal:  Nature       Date:  2014-10-05       Impact factor: 49.962

5.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 6.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 7.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

8.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

9.  Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

Authors:  Khurum H Khan; David Cunningham; Benjamin Werner; Georgios Vlachogiannis; Inmaculada Spiteri; Timon Heide; Javier Fernandez Mateos; Alexandra Vatsiou; Andrea Lampis; Mahnaz Darvish Damavandi; Hazel Lote; Ian Said Huntingford; Somaieh Hedayat; Ian Chau; Nina Tunariu; Giulia Mentrasti; Francesco Trevisani; Sheela Rao; Gayathri Anandappa; David Watkins; Naureen Starling; Janet Thomas; Clare Peckitt; Nasir Khan; Massimo Rugge; Ruwaida Begum; Blanka Hezelova; Annette Bryant; Thomas Jones; Paula Proszek; Matteo Fassan; Jens C Hahne; Michael Hubank; Chiara Braconi; Andrea Sottoriva; Nicola Valeri
Journal:  Cancer Discov       Date:  2018-08-30       Impact factor: 39.397

10.  Population dynamics of normal human blood inferred from somatic mutations.

Authors:  Henry Lee-Six; Nina Friesgaard Øbro; Mairi S Shepherd; Sebastian Grossmann; Kevin Dawson; Miriam Belmonte; Robert J Osborne; Brian J P Huntly; Inigo Martincorena; Elizabeth Anderson; Laura O'Neill; Michael R Stratton; Elisa Laurenti; Anthony R Green; David G Kent; Peter J Campbell
Journal:  Nature       Date:  2018-09-05       Impact factor: 49.962

View more
  9 in total

Review 1.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

Review 2.  Clonal Hematopoiesis: From Mechanisms to Clinical Intervention.

Authors:  Thomas Köhnke; Ravindra Majeti
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

Review 3.  Lineage tracing in human tissues.

Authors:  Calum Gabbutt; Nicholas A Wright; Ann-Marie Baker; Darryl Shibata; Trevor A Graham
Journal:  J Pathol       Date:  2022-05-05       Impact factor: 9.883

4.  Distinguishing excess mutations and increased cell death based on variant allele frequencies.

Authors:  Gergely Tibély; Dominik Schrempf; Imre Derényi; Gergely J Szöllősi
Journal:  PLoS Comput Biol       Date:  2022-04-25       Impact factor: 4.779

Review 5.  Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.

Authors:  Isidoro Cobo; Tiffany Tanaka; Christopher K Glass; Calvin Yeang
Journal:  Curr Opin Hematol       Date:  2022-01-01       Impact factor: 3.284

6.  Immunosuppressive niche engineering at the onset of human colorectal cancer.

Authors:  Chandler D Gatenbee; Ann-Marie Baker; Ryan O Schenck; Maximilian Strobl; Jeffrey West; Margarida P Neves; Sara Yakub Hasan; Eszter Lakatos; Pierre Martinez; William C H Cross; Marnix Jansen; Manuel Rodriguez-Justo; Christopher J Whelan; Andrea Sottoriva; Simon Leedham; Mark Robertson-Tessi; Trevor A Graham; Alexander R A Anderson
Journal:  Nat Commun       Date:  2022-04-04       Impact factor: 14.919

Review 7.  ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors.

Authors:  Sayaka Ueno; Tamotsu Sudo; Akira Hirasawa
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

8.  Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank.

Authors:  Shu-Hong Lin; Derek W Brown; Brandon Rose; Felix Day; Olivia W Lee; Sairah M Khan; Jada Hislop; Stephen J Chanock; John R B Perry; Mitchell J Machiela
Journal:  Cell Biosci       Date:  2021-07-23       Impact factor: 7.133

9.  Evolutionary dynamics of neoantigens in growing tumors.

Authors:  Eszter Lakatos; Marc J Williams; Ryan O Schenck; William C H Cross; Jacob Househam; Luis Zapata; Benjamin Werner; Chandler Gatenbee; Mark Robertson-Tessi; Chris P Barnes; Alexander R A Anderson; Andrea Sottoriva; Trevor A Graham
Journal:  Nat Genet       Date:  2020-09-14       Impact factor: 38.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.